Gastroenterology & Hepatology

EmailEmail    |   Bookmark Page Bookmark  |   RSS Feeds RSS  |   Print Page Print  

Clinical Trials

  • A 5-Year Non-interventional Registry Study of Humira (Adalimumab) in Patients With Moderately to Severely Active Crohn's Disease (CD)- Protocol P06-134. Status: Ongoing ~ Follow up. Principal Investigator: Lilani Perera, MD

  • SECURE: A Non-Interventional Long-term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia®) for Crohn's Disease.  Status: Ongoing ~ Enrolling. Principal  Investigator: Lilani Perera, MD                                                             

  • C13008: A Phase 3, Open-label Study to Determine the Long-term Safety and Efficacy of Vedolizumab (MLN0002) in Patients with Ulcerative Colitis and Crohn’s Disease. Status: Ongoing ~ Follow up. Principal Investigator: Lilani Perera, MD

  • STOP-HE Study -Multicenter, Randomized Phase 2B Study to Evaluate the Efficacy, Safety and Tolerability of OCR-002 (ornithine phenylacetate) in Hospitalized Patients with Cirrhosis and Associated Hyperammonemia with an Episode of Hepatic Encephalopathy. Principal Investigator: Kia Saeian, MD

  • CLARITY-Clinical Investigation to evaluate removal of the Evolution® esophageal stent–fully covered. Principal Investigator:  Kulwinder Dua, MD

  • LEGACY -A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC). Principal Investigator: Daniel Stein, MD
© 2014 Medical College of Wisconsin
Page Updated 06/09/2014